We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $9.47B | 8.67% |
25,892,025
-2,125,130
| -8% | -$753M |
|
2
Biogen
BIIB
$29.9B
| $4.35B | 3.98% |
15,700,576
-41,139
| -0.3% | -$11.6M |
|
3
Amgen
AMGN
$203B
| $4.02B | 3.68% |
15,292,213
-272,657
| -2% | -$73.1M |
|
|
4
Microsoft
MSFT
$2.84T
| $3.19B | 2.92% |
13,289,688
-1,226,552
| -8% | -$294M |
|
5
AstraZeneca
AZN
$263B
| $3.05B | 2.79% |
22,493,420
-313,635
| -1% | -$39.3M |
|
6
Texas Instruments
TXN
$255B
| $2.82B | 2.58% |
17,084,690
-261,837
| -2% | -$43.7M |
|
7
KLA
KLAC
$275B
| $2.55B | 2.34% |
67,719,540
-3,388,400
| -5% | -$118M |
|
8
FedEx
FDX
$74.5B
| $2.41B | 2.21% |
13,921,967
+43,250
| +0.3% | +$7.19M |
|
9
Adobe
ADBE
$89.5B
| $2.13B | 1.95% |
6,341,673
-63,245
| -1% | -$20.2M |
|
10
Thermo Fisher Scientific
TMO
$211B
| $2.01B | 1.84% |
3,658,574
-138,483
| -4% | -$73.4M |
|
11
Micron Technology
MU
$1.04T
| $1.99B | 1.82% |
39,739,597
-694,530
| -2% | -$38M |
|
12
Wells Fargo
WFC
$261B
| $1.97B | 1.8% |
47,710,205
-872,670
| -2% | -$38.6M |
|
13
Alphabet (Google) Class A
GOOGL
$3.91T
| $1.86B | 1.7% |
21,093,825
-490,415
| -2% | -$46.6M |
|
14
Sony
SONY
$123B
| $1.86B | 1.7% |
121,827,545
-4,411,795
| -3% | -$65.9M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.82B | 1.67% |
17,580,859
-44,646
| -0.3% | -$4.19M |
|
16
Southwest Airlines
LUV
$22.1B
| $1.76B | 1.61% |
52,198,099
-543,385
| -1% | -$19.6M |
|
17
Boston Scientific
BSX
$65.8B
| $1.74B | 1.59% |
37,651,859
+1,550
| +0% | +$67.1K |
|
18
Bristol-Myers Squibb
BMY
$127B
| $1.57B | 1.44% |
21,856,565
-281,110
| -1% | -$21.2M |
|
19
Novartis
NVS
$295B
| $1.56B | 1.43% |
17,194,880
-258,270
| -1% | -$21.8M |
|
20
Alibaba
BABA
$269B
| $1.52B | 1.39% |
17,278,627
-107,580
| -0.6% | -$8.48M |
|
|
21
Intel
INTC
$466B
| $1.5B | 1.37% |
56,571,961
+4,454,735
| +9% | +$124M |
|
22
Aecom
ACM
$9.07B
| $1.49B | 1.37% |
17,589,671
-1,600,170
| -8% | -$126M |
|
23
Raymond James Financial
RJF
$32.5B
| $1.4B | 1.28% |
13,059,887
-479,440
| -4% | -$53.8M |
|
24
Ross Stores
ROST
$76.6B
| $1.3B | 1.19% |
11,180,194
-121,310
| -1% | -$12.4M |
|
|
25
Alphabet (Google) Class C
GOOG
$3.9T
| $1.26B | 1.16% |
14,235,555
-278,685
| -2% | -$26.6M |
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.